1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Achmad, A; Bhattarai, A; Hanaoka, H; Heryanto, YD; Higuchi, T; Kanai, A; Kartamihardja, AAP; Khongorzul, E; S Ishioka, N; Shintawati, R; Sugo, Y; Tsushima, Y; Yamaguchi, A | 1 |
| Abdi, K; Arab, SS; Beiki, D; Emami, F; Geramifar, P; Pakdin-Parizi, Z; Pirooznia, N; Sabzevari, O | 1 |
| Block, I; Hansen, PL; Holmboe, S; Høilund-Carlsen, PF; Langkjær, N; Mollenhauer, J; Müller, C; Olsen, BB; Thisgaard, H | 1 |
3 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; Copper Radioisotopes; ErbB Receptors; Female; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |
Radiosynthesis, Biological Evaluation, and Preclinical Study of a
Topics: 1-Octanol; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Early Detection of Cancer; Endocytosis; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Kinetics; Lung Neoplasms; Male; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; NIH 3T3 Cells; Peptides, Cyclic; Positron-Emission Tomography; Protein Binding; Tissue Distribution; Water; Xenograft Model Antitumor Assays | 2020 |
Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
Topics: Apoptosis; Aptamers, Nucleotide; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Delivery Systems; Heterocyclic Compounds, 1-Ring; Humans; Lung Neoplasms; Neoplastic Stem Cells; Nucleolin; Phosphoproteins; Receptors, Somatostatin; RNA-Binding Proteins; Somatostatin; Tumor Cells, Cultured | 2017 |